Ibnsina Pharma (EGX: ISPH)
Egypt
· Delayed Price · Currency is EGP 3.650
-0.050 (-1.35%)
At close: Sep 12, 2024
Ibnsina Pharma Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 11, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 3,679 | 3,517 | 2,419 | 3,907 | 4,886 | 8,011 | Upgrade
|
| Market Cap Growth | -0.62% | 45.37% | -38.08% | -20.04% | -39.01% | 17.46% | Upgrade
|
| Enterprise Value | 17,641 | 15,494 | 11,020 | 10,960 | 10,282 | 9,158 | Upgrade
|
| Last Close Price | 3.65 | 3.14 | 2.16 | 3.28 | 4.10 | 6.66 | Upgrade
|
| PE Ratio | 14.66 | 18.28 | 16.05 | 14.91 | 24.95 | 27.69 | Upgrade
|
| PS Ratio | 0.09 | 0.10 | 0.11 | 0.18 | 0.26 | 0.48 | Upgrade
|
| PB Ratio | 2.25 | 2.43 | 1.92 | 2.69 | 3.58 | 6.55 | Upgrade
|
| P/FCF Ratio | -12.16 | -15.41 | -5.54 | -8.01 | 224.70 | -21.08 | Upgrade
|
| P/OCF Ratio | 60.87 | 27.95 | 6.69 | -11.48 | 19.40 | -322.59 | Upgrade
|
| EV/Sales Ratio | 0.42 | 0.46 | 0.49 | 0.50 | 0.55 | 0.55 | Upgrade
|
| EV/EBITDA Ratio | 10.35 | 12.38 | 18.70 | 13.97 | 17.09 | 12.66 | Upgrade
|
| EV/EBIT Ratio | 11.78 | 13.63 | 23.19 | 16.42 | 21.04 | 14.02 | Upgrade
|
| EV/FCF Ratio | -74.44 | -67.89 | -25.24 | -22.46 | 472.83 | -24.09 | Upgrade
|
| Debt / Equity Ratio | 9.26 | 9.06 | 7.82 | 5.49 | 4.94 | 4.48 | Upgrade
|
| Debt / EBITDA Ratio | 8.89 | 9.94 | 14.98 | 9.47 | 10.92 | 7.42 | Upgrade
|
| Debt / FCF Ratio | -64.02 | -57.54 | -22.57 | -16.35 | 310.22 | -14.40 | Upgrade
|
| Asset Turnover | - | 2.16 | 1.84 | 2.12 | 2.14 | 2.29 | Upgrade
|
| Inventory Turnover | - | 10.82 | 8.30 | 9.02 | 9.08 | 9.81 | Upgrade
|
| Quick Ratio | 0.70 | 0.68 | 0.60 | 0.66 | 0.47 | 0.41 | Upgrade
|
| Current Ratio | 1.00 | 1.00 | 1.00 | 1.03 | 1.06 | 1.09 | Upgrade
|
| Return on Equity (ROE) | - | 15.75% | 12.59% | 22.31% | 17.36% | 30.11% | Upgrade
|
| Return on Assets (ROA) | - | 4.52% | 2.46% | 4.06% | 3.51% | 5.62% | Upgrade
|
| Return on Capital (ROIC) | - | 5.53% | 2.89% | 4.75% | 4.13% | 6.69% | Upgrade
|
| Earnings Yield | 6.82% | 6.08% | 7.13% | 8.06% | 4.60% | 4.10% | Upgrade
|
| FCF Yield | -6.44% | -6.49% | -18.05% | -12.49% | 0.45% | -4.74% | Upgrade
|
| Dividend Yield | 0.00% | - | - | 2.62% | - | - | Upgrade
|
| Payout Ratio | 8.45% | 10.74% | 81.35% | 4.63% | 36.51% | 21.63% | Upgrade
|
| Buyback Yield / Dilution | - | 22.58% | -16.25% | - | -1.54% | Upgrade
| |
| Total Shareholder Return | - | 22.58% | -13.63% | - | -1.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.